Renin-angiotensin system-regulating aminopeptidase activities are modified in the pineal gland of rats with breast cancer induced by N-methyl-nitrosourea.
OBJECTIVE
Pineal function has been considered particularly as a neuroendocrine modulator in hormone responsive tumors, like the hormone-dependent mammary tumors. The complexity of the gland function, moreover, is denoted by the presence of a local renin-angiotensin-system (RAS) that regulates melatonin biosynthesis. Classically, angiotensin II (Ang II) has been considered as the effector peptide of the RAS, but Ang II is not the only active peptide. Several of its degradation products, including angiotensin III (Ang III) and angiotensin IV (Ang IV) also possess biological functions. These peptides are formed via the activity of several aminopeptidases. Our aim is to know their role in the regulation of pineal RAS and breast cancer.


METHODS
Aminopeptidase N (APN), aminopeptidase B (APB) and aminopeptidase A (aspartyl- and glutamyl-aminopeptidase, APA) activities are measured in the pineal gland of rats with breast cancer induced by N-methyl nitrosourea (NMU).


METHODS
Aminopeptidase activities were measured fluorimetrically using their corresponding aminoacyl-beta-naphthylamides as substrates.


RESULTS
Specific APN and APB activities in pineal gland of controls and NMU-treated rats were not modified. Aspartyl aminopeptidase activity significantly decreased in NMU-treated rats when compared with control group. On the contrary, glutamyl aminopeptidase activity did not show significant differences between groups.


CONCLUSIONS
We propose that the local RAS in pineal gland is modified in rats with breast cancer induced by NMU through the inhibition of AspAP activity, which may lead to increased levels of Ang II. Ang II could be responsible of the overproduction of melatonin, supporting a mechanism to restrain the promotion and/or progression of breast cancer.
Departamento de Ciencias de la Salud, Area de Fisiología, Universidad de Jaén, Jaén, Spain.
M P
MP
Carrera
M J
MJ
Ramírez-Expósito
M T
MT
Valenzuela
B
B
Dueñas
M J
MJ
García
M D
MD
Mayas
J M
JM
Martínez-Martos
D000477:Alkylating Agents / Q000633:toxicity; D000626:Aminopeptidases / Q000378:metabolism*; D000804:Angiotensin II / Q000378:metabolism; D000818:Animals; D005260:Female; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000201:enzymology* / Q000503:physiopathology; D008550:Melatonin / Q000378:metabolism; D008770:Methylnitrosourea / Q000633:toxicity; D010870:Pineal Gland / Q000201:enzymology*; D051381:Rats; D012084:Renin-Angiotensin System / Q000502:physiology*
D000477:Alkylating Agents; D000804:Angiotensin II; D008770:Methylnitrosourea; D000626:Aminopeptidases; D008550:Melatonin